Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1677
This examiner grants 32% of resolved cases
Chau Nguyen Bich Tran is an examiner in Tech Center 1600, Art Unit 1677. The examiner has 76 resolved cases. The data shows an allowance rate of 31.6 percent and an interview lift of 45.2 percent. The median days to allowance for these cases is 1464.
The 45.2 percent interview lift is a significant figure when compared to the 31.6 percent base allowance rate. This indicates that conducting an interview is a method for increasing the likelihood of an allowance. The 1464 day median pendency is the timeframe applicants can expect when navigating the resolved cases handled by this examiner in Art Unit 1677. Practitioners can consider how these metrics influence the overall prosecution timeline.
With 76 resolved cases, the examiner's statistics provide a view of the prosecution landscape. Practitioners can use the 31.6 percent allowance rate to assess the probability of a grant. The 45.2 percent lift and the Tech Center 1600 environment are factors for prosecution strategy. These data points help in setting expectations for clients.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17045344 | METHODS, USES AND KITS FOR MONITORING OR PREDICTING RESPONSE TO PERIODONTAL DISEASE TREATMENT | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 17783180 | COMPOSITIONS AND METHODS FOR IDENTIFYING AND MODULATING THROMBOTIC CONDITIONS IN A CANCER PATIENT | Final Rejection | Beth Israel Deaconess Medical Center, Inc. |
| 16625137 | SANDWICH-TYPE ASSAYS USING DECREASING SIGNAL PORTIONS OF DOSE RESPONSE CURVE TO MEASURE ANALYTES, INCLUDING ANALYTES AT HIGH CONCENTRATION | Non-Final OA | Becton, Dickinson and Company |
| 18270749 | BIOMARKER FOR DETERMINING FERTILITY, AND DETERMINING METHOD USING SAME | Non-Final OA | TOSOH CORPORATION |
| 18643136 | METHOD AND DEVICE FOR EVALUATING IMMUNE CELLS USING MAGNETIC PARTICLES | Non-Final OA | UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) |
| 18353056 | B CELL MONITORING REAGENT PANEL AND REAGENT KIT FOR ANALYZING B CELL SUBSETS IN ANTI-CD20 TREATED AUTOIMMUNE PATIENTS | Non-Final OA | CYTEK BIOSCIENCES, INC. |
| 17763992 | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF PERIPHERAL ARTERIAL DISEASE | Final Rejection | UNITY HEALTH TORONTO |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy